The recent issue of Clinical Laboratory International features the ongoing search and characterization of tumor biomarkers for potential use a liquid biopsy in Retinoblastoma. This work is lead by Liya Xu, in collaboration with Drs. Jesse Berry and David Cobrinik of CHLA. Read more on page 6 of CLI and check out the recent publications …
As part of From Where We Are, a newscast by USC Annenberg School for Communication and Journalism, Professor Kuhn is featured to discussion the use of anion exchange purification to measure stable isotopes in human blood samples and its clinical application in cancer detection. Listen on to the Annenberg Radio Story starting at 22:42 And …
Presenters: Peter Kuhn, PhD and Jorge Nieva, MD. University of Southern California, Los Angeles, CA Abstract: The Current Status of Tumor BiomarkersThe past decade has seen tremendous advances in cancer care driven largely by better understanding of cancer genetics and biology. Characterization of the DNA changes driving cancer formation is now routine and it seems …
Presenter James B. Hicks, PhD. University of Southern California, Los Angeles, CA Description Cancer is a genetic disease that evolves over time and in response to treatment, whether in model systems or in the setting of human disease. It is therefore imperative to create tools to assess genomic and transcriptomic complexity in order to understand …
Continue reading “#aacr19: Deconvoluting Tumor Heterogeneity Using Single-Cell Genomics”
Presenters: Paymaneh D. Malihi1, Ryon P. Graf2, Carmen Ruiz Velasco1, Anand Kolatkar1, Angel E. Rodriguez2, Jerry Lee2, Ramsay Sutton2, Paul G. Corn3, Christopher J. Logothetis3, Ana M. Aparicio3, James Hicks1, Ryan Dittamore2, Amado J. Zurita3, Peter Kuhn1. 1University of Southern California, Los Angeles, CA; 2EPIC Sciences, San Diego, CA; 3MD Anderson Cancer Center, Houston, TX Abstract: A …